NICE HealthTech programme manual (methods consultation) | Methods / process manual consultation | NICE process and methods | |
Seladelpar for previously treated primary biliary cholangitis [ID6429] | Draft guidance | Technology appraisal guidance | |
Serplulimab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer [ID6346] | Draft guidance | Technology appraisal guidance | |
Dostarlimab with platinum-based chemotherapy for advanced or recurrent endometrial cancer with microsatellite stability or mismatch repair proficiency [ID6415] | Draft guidance | Technology appraisal guidance | |
Glofitamab with gemcitabine and oxaliplatin for treating relapsed or refractory diffuse B-cell lymphoma [ID6202] | Draft guidance | Technology appraisal guidance | |
Dupilumab for treating severe chronic rhinosinusitis with nasal polyps (review of TA648) [ID6480] | Draft guidance | Technology appraisal guidance | |
Brexucabtagene autoleucel for treating relapsed or refractory mantle cell lymphoma after 2 or more systemic treatments (review of TA677) [ID6325] | Draft guidance | Technology appraisal guidance | |